Roberto Burioni Selected Research

Arbovirus Infections

1/2013

Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto Burioni Research Topics

Disease

23	Infections 01/2020 - 11/2002
9	Human Influenza (Influenza) 12/2022 - 07/2003
3	Multiple Sclerosis 08/2020 - 08/2014
3	Progressive Multifocal Leukoencephalopathy 01/2016 - 01/2012
3	Virus Diseases (Viral Diseases) 08/2008 - 07/2003
2	Atherosclerosis 01/2016 - 01/2012
2	Atherosclerotic Plaque (Atheroma) 01/2012 - 08/2009
2	Cryoglobulinemia 01/2012 - 06/2008
2	Persistent Infection 06/2010 - 10/2006
2	Vesicular Stomatitis 10/2004 - 11/2002
1	Infertility (Sterility) 04/2024
1	COVID-19 08/2020
1	Necrosis 03/2016
1	Metabolic Diseases (Metabolic Disease) 01/2016
1	Inflammation (Inflammations) 01/2016
1	Mycoses (Diseases, Fungus) 01/2015
1	Schistosomiasis haematobia (Schistosomiasis haematobium) 09/2014
1	Demyelinating Diseases (Demyelinating Disease) 08/2014
1	Parasitic Diseases (Parasitic Disease) 02/2014
1	Animal Diseases 03/2013
1	Scrapie 03/2013
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 03/2013
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Arbovirus Infections 01/2013
1	Necrotizing Enterocolitis 10/2012
1	Acute Coronary Syndrome 01/2012
1	Keratitis 09/2005
1	Reinfection 11/2002

Drug/Important Bio-Agent (IBA)

11	Monoclonal AntibodiesIBA 05/2015 - 07/2003
6	Antiviral Agents (Antivirals)IBA 08/2020 - 11/2002
6	VaccinesIBA 01/2017 - 10/2004
6	AntibodiesIBA 05/2015 - 11/2002
5	Proteins (Proteins, Gene)FDA Link 03/2013 - 10/2006
4	Neutralizing AntibodiesIBA 01/2019 - 10/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2005
4	EpitopesIBA 05/2015 - 10/2006
3	AntigensIBA 03/2016 - 06/2008
3	Natalizumab (Tysabri)FDA Link 01/2016 - 01/2012
3	Formaldehyde (Formol)FDA Link 04/2015 - 02/2014
3	Immunoglobulin Fab FragmentsIBA 03/2010 - 07/2003
3	Glycoproteins (Glycoprotein)IBA 12/2009 - 11/2002
2	Hemagglutinins (Hemagglutinin)IBA 12/2022 - 01/2011
2	InterferonsIBA 08/2020 - 03/2016
2	Ether (Diethyl Ether)IBA 09/2014 - 02/2014
2	Broadly Neutralizing AntibodiesIBA 08/2008 - 01/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2024
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Immunoglobulin G (IgG)IBA 01/2018
1	NucleosidesIBA 01/2018
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2017
1	Interleukin-2 (IL2)IBA 03/2016
1	CytokinesIBA 03/2016
1	Apolipoproteins E (ApoE)IBA 01/2016
1	Immunomodulating AgentsIBA 08/2014
1	Raltegravir Potassium FDA Link 11/2013
1	dolutegravirIBA 11/2013
1	PrionsIBA 03/2013
1	Protein Isoforms (Isoforms)IBA 03/2013
1	Prion ProteinsIBA 03/2013
1	RNA (Ribonucleic Acid)IBA 03/2013
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2012
1	Fungal DNAIBA 10/2012
1	Immunoglobulins (Immunoglobulin)IBA 01/2012
1	transgelinIBA 01/2012
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 10/2011
1	Immunoglobulin M (IgM)IBA 06/2008
1	CryoglobulinsIBA 06/2008
1	Ribavirin (Virazole)FDA LinkGeneric 10/2006
1	Interferon-alpha (Interferon Alfa)IBA 10/2006
1	Immunoglobulin FragmentsIBA 11/2002

Therapy/Procedure

5	Therapeutics 04/2016 - 10/2006
1	Phage Therapy 01/2017
1	Immunotherapy 11/2012